Laboratory for tissue biology and therapeutic engineering (LBTI), CNRS, Université de Lyon, UMR 5305, 7 Passage du Vercors, Lyon cedex 7 69367, France.
Université de Nantes, Oniris, CHU Nantes, INSERM, Regenerative Medicine and Skeleton, RMeS, UMR 1229, Nantes F-44000, France.
Acta Biomater. 2022 Mar 1;140:324-337. doi: 10.1016/j.actbio.2021.11.036. Epub 2021 Nov 26.
Injectable hydrogels that polymerize directly in vivo hold significant promises in clinical settings to support the repair of damaged or failing tissues. Existing systems that allow cellular and tissue ingrowth after injection are limited because of deficient porosity and lack of oxygen and nutrient diffusion inside the hydrogels. Here is reported for the first time an in vivo injectable hydrogel in which the porosity does not pre-exist but is formed concomitantly with its in situ injection by a controlled effervescent reaction. The hydrogel tailorable crosslinking, through the reaction of polyethylene glycol with lysine dendrimers, allows the mixing and injection of precursor solutions from a dual-chamber syringe while entrapping effervescently generated CO bubbles to form highly interconnected porous networks. The resulting structures allow preserving modular mechanical properties (from 12.7 ± 0.9 to 29.9 ± 1.7 kPa) while being cytocompatible and conducive to swift cellular attachment, proliferation, in-depth infiltration and extracellular matrix deposition. Most importantly, the subcutaneously injected porous hydrogels are biocompatible, undergo tissue remodeling and support extensive neovascularisation, which is of significant advantage for the clinical repair of damaged tissues. Thus, the porosity and injectability of the described effervescent hydrogels, together with their biocompatibility and versatility of mechanical properties, open broad perspectives for various regenerative medicine or material applications, since effervescence could be combined with a variety of other systems of swift crosslinking. STATEMENT OF SIGNIFICANCE: A major challenge in hydrogel design is the synthesis of injectable formulations allowing easy handling and dispensing in the site of interest. However, the lack of adequate porosity inside hydrogels prevent cellular entry and, therefore, vascularization and tissue ingrowth, limiting the regenerative potential of a vast majority of injectable hydrogels. We describe here the development of an acellular hydrogel that can be injected directly in situ while allowing the simultaneous formation of porosity. Such hydrogel would facilitate handling through injection while providing a porous structure supporting vascularization and tissue ingrowth.
可在体内直接聚合的注射水凝胶在支持受损或失效组织修复的临床环境中具有重要的应用前景。现有的允许注射后细胞和组织向内生长的系统由于其多孔性不足以及水凝胶内部缺乏氧气和营养物质扩散而受到限制。本文首次报道了一种可在体内注射的水凝胶,其多孔性不是预先存在的,而是通过受控的冒泡反应在原位注射的同时形成的。通过聚乙二醇与赖氨酸树枝状大分子的反应,水凝胶可进行可调节的交联,允许在双室注射器中混合和注射前体溶液,同时包埋冒泡产生的 CO2 气泡,以形成高度互联的多孔网络。所得到的结构允许保持模块化的机械性能(从 12.7 ± 0.9 到 29.9 ± 1.7 kPa),同时具有细胞相容性,并有利于快速细胞附着、增殖、深入渗透和细胞外基质沉积。最重要的是,皮下注射的多孔水凝胶具有生物相容性,经历组织重塑并支持广泛的新生血管化,这对于受损组织的临床修复具有重要优势。因此,所描述的冒泡水凝胶的多孔性和可注射性,以及它们的生物相容性和机械性能的多功能性,为各种再生医学或材料应用开辟了广阔的前景,因为冒泡作用可以与多种其他快速交联系统结合使用。